PMID: 11909833Mar 23, 2002Paper

Helicobacter pylori susceptibility testing by disc diffusion

The Journal of Antimicrobial Chemotherapy
Cliodna McNultyPHLS Helicobacter Working Group

Abstract

The bacterium Helicobacter pylori is found in c. 40% of the population and is responsible for the development of duodenal disease. Triple treatment with a proton-pump inhibitor or bismuth salt plus two antibiotics is now commonplace in all patients diagnosed. As antibiotic resistance reduces treatment efficacy, it is time to consider routine susceptibility testing to guide individual patient treatment and surveillance of antibiotic resistance. There are no published nationally agreed standards for disc diffusion testing of H. pylori. After reviewing the literature, we recommend the following method for disc diffusion tests. A suspension of cultures < or = 4 days old equivalent to McFarland Standard no. 4 (10(8) cfu/mL) should be used on Mueller-Hinton or Columbia agar base with 5-10% blood, using a metronidazole disc strength of 5 Ig and a clarithromycin disc strength of 2 microg. Anaerobic pre-incubation of plates is unnecessary. A H. pylori control susceptible to metronidazole (e.g. NCTC 12822) should be used. Zone sizes with the Mueller-Hinton agar base for metronidazole testing are <16 mm resistant, 16-21 mm intermediate and >21 mm susceptible. We suggest that isolates in the intermediate zone should be re-tested by Etest. ...Continue Reading

References

Jan 1, 1992·Antimicrobial Agents and Chemotherapy·H RautelinT U Kosunen
Sep 1, 1991·Journal of Clinical Microbiology·Y GlupczynskiE Yourassowsky
Dec 1, 1985·Antimicrobial Agents and Chemotherapy·C A McNultyR Wise
Sep 1, 1986·Antimicrobial Agents and Chemotherapy·T LambertP Courvalin
Feb 7, 1994·NIH Consensus Statement
Jul 1, 1993·The Journal of Antimicrobial Chemotherapy·A M HirschlM L Rotter
Jan 1, 1993·The Journal of Antimicrobial Chemotherapy·G CederbrantA Ljungh
Apr 1, 1997·Alimentary Pharmacology & Therapeutics·K BodgerR V Heatley
Jun 1, 1997·Journal of Clinical Microbiology·T H HenriksenA Lia
Mar 25, 1998·The Journal of Antimicrobial Chemotherapy·M A JorgensenS L Hazell
May 16, 1998·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·K WeissC Restieri
Jul 24, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J V Solnick
Nov 21, 1998·Gut·M Langman, P Boyle
Jan 29, 1999·Lancet·L TeareI Tiwari
Jan 29, 1999·Lancet·J Fleming, G Pike
Mar 17, 1999·Gut·R J Owen
Apr 29, 1999·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S L Hazell
Jun 25, 1999·The Journal of Antimicrobial Chemotherapy·M P DoreA R Sepulveda
Jun 26, 1999·The Journal of Antimicrobial Chemotherapy·D B HoellmanP C Appelbaum
Oct 30, 1999·Antimicrobial Agents and Chemotherapy·F MégraudC F Burman
Jan 5, 2000·BMJ : British Medical Journal·W A de Boer, G N Tytgat
Mar 11, 2000·Lancet·J Danesh, R E Pounder
Apr 8, 2000·International Journal of Antimicrobial Agents·M I BrenciagliaF Dubini
Sep 1, 2000·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M HeepN Lehn
Jan 11, 2001·The Journal of Antimicrobial Chemotherapy·E CercenadoE Bouza

❮ Previous
Next ❯

Citations

Jul 8, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·N SainsusR Hofmann-Lehmann
Jun 13, 2012·Antimicrobial Agents and Chemotherapy·Suchandra GoswamiPratap K Das
Jul 6, 2002·BMJ : British Medical Journal·Peter J Jenks
Dec 24, 2005·Annals of Clinical Microbiology and Antimicrobials·Shaik Mahaboob AliNiyaz Ahmed
Jul 20, 2010·Diagnostic Microbiology and Infectious Disease·Lyudmila BoyanovaIvan Mitov
Nov 7, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Kianoosh DadashzadehAbolfazl Akbarzadeh
Mar 20, 2012·Journal of Ethnopharmacology·Larissa Maria Scalon LemosDomingos Tabajara de Oliveira Martins
Jun 30, 2016·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Judit Alarcón-MillánAdolfo Román-Román
May 6, 2014·Journal of Pediatric Gastroenterology and Nutrition·Hamza KarabiberAli Ozer
May 20, 2017·World Journal of Gastroenterology : WJG·Nazlı ArslanEbru Demiray-Gürbüz
May 20, 2004·Journal of Medical Microbiology·Ewen A B CameronSimon G J Williams
Nov 18, 2003·Helicobacter·Hilpi RautelinFrancis Mégraud
Feb 20, 2019·International Journal of Molecular Sciences·Genzhu WangXuefu You
Dec 17, 2020·Drug Design, Development and Therapy·Dalia A GaberRehab M Alsawi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.